Chronic daily headache

New England Journal of Medicine

Volumn 354, Issue 2, 2006, Pages 158-165

  Dodick, David W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BOTULINUM TOXIN A; BUTALBITAL; CLONIDINE; DIHYDROERGOTAMINE MESILATE; ERGOTAMINE; ERGOTAMINE TARTRATE; EXCEDRIN; FLUOXETINE; GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE DERIVATIVE; PHENOBARBITAL; PREDNISONE; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VALPROATE SEMISODIUM; NARCOTIC AGENT;

ADULT; ALOPECIA; ANALGESIA; ANAMNESIS; ANOREXIA; ANXIETY; ARTICLE; ASTHENIA; ATAXIA; BODY POSITION; BRADYCARDIA; CASE REPORT; CHRONIC DAILY HEADACHE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONCENTRATION LOSS; CONSTIPATION; COORDINATION DISORDER; DIPLOPIA; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EXERCISE; FATIGUE; FEEDBACK SYSTEM; FEMALE; FEVER; HEART PALPITATION; HUMAN; HYPOTENSION; INSOMNIA; MIGRAINE; MOOD DISORDER; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NECK PAIN; OBESITY; PARESTHESIA; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAXATION TRAINING; SIDE EFFECT; SLEEP; SLEEP DISORDER; SOMNOLENCE; THOUGHT DISORDER; TINNITUS; TRANSFORMED MIGRAINE; TREATMENT INDICATION; TREATMENT WITHDRAWAL; TREMOR; VALSALVA MANEUVER; WEIGHT REDUCTION; WITHDRAWAL SYNDROME; WORK; XEROSTOMIA; HEADACHE AND FACIAL PAIN; REVIEW;

ADULT; ANALGESICS; FEMALE; HEADACHE DISORDERS; HUMANS; MIGRAINE DISORDERS; NARCOTICS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 30444460269     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp042897     Document Type: Article

References (43)

1. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996;47:871-5.
2. Headache Classification Subcommit-tee of the International Headache Society. The international classification of headache disorders, 2nd edition. Cephalalgia 2004;24:Suppl 1:1-160.
3. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.
4. Castillo J, Munoz J, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-6.
5. Lanteri-Minet M, Auray JP, El Hasnaoui A. Prevalence and description of chronic daily headache in the general population of France. Pain 2003;102:143-9.
6. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987;27:102-6.
7. D'Amico D, Usai S, Grazzi L, et al. Quality of life and disability in primary chronic daily headache. Neurol Sci 2003;24:Suppl 2:S97-S100.
8. Guitera V, Munoz P, Castillo J, Pascual J. Quality of life in chronic daily headache: a study in a general population. Neurology 2002;58:1062-5.
9. Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 2001;89:285-92.
10. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-9.
11. Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep 2002;6:486-91.
12. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology 2000;54:314-9.
13. Zwart JA, Dyb G, Hagen K, et al. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT study. Neurology 2003;61:160-4.
14. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 2003; 60:1682-3.
15. Welch KM, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 2002;15:287-95.
16. Mathew NT, Stubits E, Nigam MR. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982;22:66-8.
17. Saper JR. Daily chronic headache. Neurol Clin 1990;8:891-901.
18. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache 1990;30:634-8.
19. Saper JR. Ergotamine dependency. Headache 1987;27:435-8.
20. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004;62:1338-42.
21. Bigal ME, Sheftell FD, Rapoport AM, Lipton RB, Tepper SJ. Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002;22:432-8.
22. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001;57:1694-8.
23. Verri AP, Proietti Cecchini A, Galli C, Granella F, Sandrini G, Nappi G. Psychiatric comorbidity in chronic daily headache. Cephalalgia 1998;18:Suppl 21:45-9.
24. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001;285:2208-15.
25. Spira PJ, Beran RG. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 2003;61:1753-9.
26. Saper JR, Silberstein SD, Lake AE III, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994;34:497-502.
27. Saper JR, Lake AE III, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002;42:470-82.
28. Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache 2001;41:271-8.
29. Krymchantowski AV, Silva MT, Barbosa JS, Alves LA. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 2002;42:510-4.
30. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia 2003;23:820-4.
31. Mathew NT, Frishberg BM, Gawel M, et al. Botulinum toxin type A (Botox) for the treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005;45:293-307.
32. Silberstein SD, Neto W, Schmitt J, et al. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004;61:490-5.
33. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291:965-73.
34. Freitag FG, Collins SD, Carlson HA, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002;58:1652-9.
35. Limmroth V, Katsarava Z. Medication overuse headache. Curr Opin Neurol 2004;17:301-6.
36. Saper JR, Lake AE III, Hamel RL, et al. Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology 2004;62:1687-94.
37. Pageler L, Katsarava Z, Limmroth V, et al. Prednisone in the treatment of medication withdrawal headache following medication overuse headache: a placebo-controlled, double-blind, and randomized pilot study. Cephalalgia 2004;24:72. abstract.
38. Smith TR. Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headache. Headache 2002;42:175-7.
39. Freitag FG, Lake A III, Lipton R, et al. Inpatient treatment of headache: an evidence-based assessment. Headache 2004;44:342-60.
40. Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001;45:229-35.
41. Pini LA, Cicero AF, Sandrini M. Longterm follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001;21:878-83.
42. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-62.
43. Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004;127:220-30.